Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203133
Company: AMNEAL PHARMS LLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DEXTROMETHORPHAN POLISTIREX DEXTROMETHORPHAN POLISTIREX EQ 30MG HYDROBROMIDE/5ML SUSPENSION, EXTENDED RELEASE;ORAL Over-the-counter None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/28/2017 ORIG-1 Approval

Label is not available on this site.

DEXTROMETHORPHAN POLISTIREX

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

SUSPENSION, EXTENDED RELEASE;ORAL; EQ 30MG HYDROBROMIDE/5ML
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD Application No. Company
DELSYM DEXTROMETHORPHAN POLISTIREX EQ 30MG HYDROBROMIDE/5ML SUSPENSION, EXTENDED RELEASE;ORAL Over-the-counter Yes 018658 RB HLTH
DEXTROMETHORPHAN POLISTIREX DEXTROMETHORPHAN POLISTIREX EQ 30MG HYDROBROMIDE/5ML SUSPENSION, EXTENDED RELEASE;ORAL Over-the-counter No 203133 AMNEAL PHARMS LLC
DEXTROMETHORPHAN POLISTIREX DEXTROMETHORPHAN POLISTIREX EQ 30MG HYDROBROMIDE/5ML SUSPENSION, EXTENDED RELEASE;ORAL Over-the-counter No 091135 TRIS PHARMA INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English